|
Acquisitions - Additional Information (Detail) (USD $)
|
12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jul. 22, 2013
Bionostics Holdings, Ltd
|
Jun. 30, 2014
Bionostics Holdings, Ltd
|
Jun. 30, 2013
Bionostics Holdings, Ltd
|
Jul. 22, 2013
Bionostics Holdings, Ltd
Developed technology
|
Jul. 22, 2013
Bionostics Holdings, Ltd
Trade names
|
Jul. 22, 2013
Bionostics Holdings, Ltd
Non-compete agreement
|
Jul. 22, 2013
Bionostics Holdings, Ltd
Customer relationships
|
Apr. 30, 2014
PrimeGene
|
Jun. 30, 2014
PrimeGene
|
Apr. 30, 2014
PrimeGene
Developed technology
|
Apr. 30, 2014
PrimeGene
Trade names
|
Apr. 30, 2014
PrimeGene
Non-compete agreement
|
Apr. 30, 2014
PrimeGene
Customer relationships
|
|
| Business Acquisition [Line Items] | ||||||||||||||||
| Acquired intangible assets | $ 14,400,000 | $ 2,700,000 | $ 2,400,000 | $ 41,000,000 | $ 2,200,000 | $ 3,000,000 | $ 300,000 | $ 9,100,000 | ||||||||
| Acquired intangible assets, useful life (in years) | 9 years | 5 years | 3 years | 14 years | 9 years | 11 years | 3 years | 9 years | ||||||||
| Business acquisition, transaction costs | 500,000 | 600,000 | 400,000 | |||||||||||||
| Cash paid, net of cash acquired | 109,180,000 | 0 | 0 | 103,149,000 | 6,031,000 | |||||||||||
| Net Sales | 33,100,000 | 700,000 | ||||||||||||||
| Net income (loss) | 2,100,000 | (100,000) | ||||||||||||||
| Amortization of intangible assets | 5,500,000 | 300,000 | ||||||||||||||
| Costs recognized on sale of acquired inventory | $ 7,480,000 | $ 4,501,000 | $ 7,573,000 | $ 1,500,000 | $ 200,000 | |||||||||||